Abstract:Abstract Background Short-chain fatty acids (SCFAs), the main metabolites produced by bacterial fermentation of dietary fiber, possess neuroactive properties. The present study aimed to explore whether SCFAs-butyrate can repress neuroinflammation and alleviate cognitive impairment via improving gut mucosal barrier function and mediating tryptophan metabolism in LDLR−/− mice. Methods LDLR−/− mice were fed an atherosclerotic diet with 1.25% cholesterol and 40% calories from fat and concomitantly treated by intragastric administration with either normal saline as model group or 400mg/kg/day sodium butyrate for 8 weeks. Results For gut barrier function, butyrate increased expression of tight junction protein, and inhibited intestinal inflammatory pathways by targeting the toll-like receptor 4 signaling and the nod-like receptors domain containing 3 (NLRP3) inflammasome. Subsequently, butyrate reduced not only the serum lipopolysaccharide level but also its capability to cross the blood-brain barrier, leading to the suppression of tau phosphorylation and the improvement of neuroinflammation by inhibiting the increase in reactive microglia and astrocytes, and blocking NLRP3 inflammasome activation in the cortex and hippocampus. Final behavioral tests indicated that butyrate delayed cognitive impairment via decreasing latency to the platform and lengthening swimming distance in the target quadrant. Nevertheless, butyrate showed no effect on serotonin, indoleacetic acid, L-kynurenine, niacinamide, and their metabolites, indicating that the observed effects on cognitive function are unrelated to the tryptophan metabolism. Conclusion In summary, the present study provided the novel experimental evidence that butyrate played a neuroprotective role by targeting the NLRP3 inflammasome. The reduction of neuroinflammation may be related to the improvement of gut mucosal barrier function and the decrease of the penetration of intestinal endotoxin from the gut to the central nervous system.

Effects of butyrate on intestinal ischemia-reperfusion injury via the HMGB1-TLR4-MyD88 signaling pathway

Butyrate Attenuates Intestinal Inflammation in Crohn’s Disease by Suppressing Pyroptosis of Intestinal Epithelial Cells Via the Cgsa-Sting-nlrp3 Axis

Protective Effects of Butyrate on Renal Ischemia-Reperfusion Injury in Rats.

The protective effects of dietary Clostridium butyricum supplementation on hepatic ischemia reperfusion injury in rats

Butyrate Prevents the Pathogenic Anemia‐Inflammation Circuit by Facilitating Macrophage Iron Export

P036 Microbiota Metabolite Butyrate Attenuates Intestinal Inflammation Through Autophagy Activation

Bifidobacterium longum GL001 alleviates rat intestinal ischemia–reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism

Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease

Butyrate attenuates intestinal inflammation in Crohn's disease by suppressing pyroptosis of intestinal epithelial cells via the cGSA-STING-NLRP3 axis

An Important Role of Interleukin-10 in Counteracting Excessive Immune Response in HT-29 Cells Exposed to Clostridium Butyricum

Butyric Acid Ameliorates Myocardial Fibrosis by Regulating M1/M2 Polarization of Macrophages and Promoting Recovery of Mitochondrial Function

Roseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway

TLR4 inhibitors through inhibiting (MYD88-TRIF) pathway, protect against experimentally-induced intestinal (I/R) injury

Butyrate Alleviates Cognitive Impairment by Improving Gut Mucosal Barrier Function and Blocking Neuroinflammatory Signaling in LDLR-/- Mice

Immunomodulatory effects of Clostridium butyricum on human enterocyte-like HT-29 cells

Bryostatin-1 attenuates intestinal ischemia/reperfusion-induced intestinal barrier dysfunction, inflammation, and oxidative stress via activation of Nrf2/HO-1 signaling

Lactobacillus reuteri mitigates hepatic ischemia/reperfusion injury by modulating gut microbiota and metabolism through the Nrf2/HO-1 signaling

Butyrate Ameliorates Intestinal Epithelial Barrier Injury Via Enhancing Foxp3+ Regulatory T-Cell Function in Severe Acute Pancreatitis Model

BUTYRATE-PRODUCING BACTERIA INCREASE GUT MICROBIOTA DIVERSITY TO DELAY INTESTINAL INFLAMMAGING

Quantitative increase in short-chain fatty acids, especially butyrate protects kidney from ischemia/reperfusion injury

Butyrate ameliorated ferroptosis in ulcerative colitis through modulating Nrf2/GPX4 signal pathway and improving intestinal barrier